While there are reports indicating that PRKCB can promote mammary tumorigenesis [75], enhance breast cancer cells growth and cyclin D1expression [76], and has the potential as therapeutic target [77], there is also a report indicating it may inhibit tumor growth and metastasis [78]. This evidence concerns the gene PRKCB and breast cancer.